leisure time -WSS

leisure time

author：comprehensive 2025-09-06 10:59:12 - browse：492

In 2020, James Sulzer’s personal and professional lives suddenly intersected after his then 4-year-old daughter sustained a devastating injury. As a researcher and associate professor in physical medicine and rehabilitation at Case Western Reserve University, Sulzer has spent his life tinkering with tools that help patients with neurological conditions. But after his child’s traumatic brain injury, Sulzer’s eyes were opened to how much his field was missing about the real experiences of families dealing with recovery.

In this week’s episode, Sulzer speaks with host Torie Bosch about the importance of centering patients in research and treatment. “For some reason in rehabilitation research, we’ve kind of lost that ethos,” Sulzer says. “It hasn’t become part of our DNA anymore.”

Read Sulzer’s full essay: “After 20 years in rehabilitation research, my young daughter’s traumatic brain injury transformed my mind and my career.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Drug repurposing or repositioning? The language matters
Next article： At ASCO, AstraZeneca reports strong data for breast cancer drug

Wikipedia

WSS

With trial win, GSK could get blood cancer drug back on market

Ultragenyx gene therapy for rare liver ailment succeeds in late

Shifting the focus from loneliness to social health

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

FDA's Pazdur wants cancer trials to range beyond China alone

FDA's Pazdur wants cancer trials to range beyond China alone

hotspot

leisure time

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Nurses recount patients attacks

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

How one medical school became remarkably diverse

App could help diagnose ear infections more accurately — and at home

Cancer drug shortages should be causing more outrage

Shifting the focus from loneliness to social health

Jerome Adams on the need for new antivirals for Covid

Neuroscience’s long legacy of racism

entertainment

UnitedHealth increases loan offers after Change Healthcare outage

CVS Caremark has created a new ploy: the drug ‘rebate credit’

AstraZeneca to buy developer of next

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Ionis drug prevents swelling attacks due to hereditary angioedema

Ultragenyx gene therapy for rare liver ailment succeeds in late

leisure time

Wikipedia

hotspot

explore